Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.
Interleukin 6 (IL-6) is an important regulator of the acute phase response, T cell function, and terminal B cell differentiation. Excessive or inappropriate production of this cytokine may be involved in a variety of autoimmune and neoplastic disorders. To investigate the consequences of dysregulate...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1990
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296765/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2384605/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114749 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|